University Compounding Pharmacy, a leader in personalized medicine since 1999, has announced it is rebranding as MediVera Compounding Pharmacy™. This change coincides with the company's robust growth driven by new product introductions, nationwide expansion, and a successful differentiation strategy for its quality products and services.
Despite the new name, the company's ownership and dedicated team remain unchanged, ensuring the continuity of the high-level service and exceptional care that healthcare providers and patients have trusted for over two decades.
In recent years, the company has experienced substantial revenue growth. Enhanced product offerings, nationwide expansion, and a strong market position through differentiated quality products and services, such as the Impressed Advantage program, have enabled the company to double its revenue from 2022 to 2023. The growth momentum is expected to continue, with projections to double revenue year-over-year once again.
“Differentiation is and will continue to be an important growth driver for our company. With the Impressed Advantage customer service program, we are making the prescription process easier, faster, and more convenient for both doctors and their patients,” said Bradley McCloskey, PharmD, CEO. “As we continue to launch more product offerings and expand into more states within the next few months, 2024 is poised to become a year of strong growth as we expand our footprint into 14 additional states.”
MediVera Compounding Pharmacy is currently licensed in and ships to the following 33 states: AZ, CN, CO, DE, FL, GA, IA, ID, IL, IN, KY, MA, MD, ME, MI, MN, MO, MT, NC, NH, NJ, NY, OH, PA, RI, SC, SD, TN, VA, VT, WA, WI, WY.
For more details about MediVera Compounding Pharmacy and its services, please visit mediverarx.com.
